Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06225583 · ClinicalTrials.gov registry record

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

A clinical trial of Lower Back Pain and Bertolotti's Syndrome, sponsored by The Cleveland Clinic.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT06225583: Recruiting study of Lower Back Pain and Bertolotti's Syndrome, sponsored by The Cleveland Clinic.

NCT06225583 is a study of Lower Back Pain and Bertolotti's Syndrome that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 40 participants, above the 18-participant average among 4 other Lower Back Pain trials with a reported enrollment target (122% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06225583, a study of Lower Back Pain and Bertolotti's Syndrome, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-17
Est. Completion 2026-12-31
The Cleveland Clinic

688 total trials

What NCT06225583 shows while recruiting

NCT06225583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, above the 18-participant average among 4 other Lower Back Pain trials with a reported enrollment target (122% higher).

The record links to 2 conditions, with Lower Back Pain appearing as the primary indexed condition, and to 0 interventions.

NCT06225583 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06225583 about?

NCT06225583 is a clinical study titled "Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers". The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be an...

What is the current status of trial NCT06225583?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-01-17. Estimated completion is 2026-12-31.

What conditions does trial NCT06225583 study?

This clinical trial studies the following conditions: Lower Back Pain, Bertolotti's Syndrome.

Who is sponsoring clinical trial NCT06225583?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06225583 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06225583, the US trial registry maintained by the National Library of Medicine. NCT06225583 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.